The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multiple myeloma (MM) therapy within a Medicare insured patient population: Role of initial care setting and socioeconomic status.
 
Amy J. Davidoff
Honoraria - Celgene (I); Jazz Pharmaceuticals (I); Kyowa Hakko Kirin (I); Tolero Pharmaceuticals (I)
Consulting or Advisory Role - Abbvie (I); Amgen; Celgene (I)
Research Funding - Boehringer Ingelheim (Inst); Celgene (Inst)
Other Relationship - PhRMA Foundation
 
Jessica B. Long
Employment - New Century Hospice (I)
 
Jan Philipp Bewersdorf
No Relationships to Disclose
 
Rory Shallis
No Relationships to Disclose
 
Amer Methqal Zeidan
Honoraria - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cardinal Health; Celgene; Daiichi Sankyo; Epizyme; Incyte; Ions Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Consulting or Advisory Role - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cardinal Health; Celgene; Daiichi Sankyo; Epizyme; Incyte; Ions Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer; Trovagene
 
Nikolai Alexandrovich Podoltsev
Honoraria - Celgene
Consulting or Advisory Role - Agios; Blueprint Medicines; Bristol-Myers Squibb; CTI BioPharma Corp; Incyte; Novartis; Pfizer
Research Funding - AI Therapeutics (Inst); Arog (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); CTI BioPharma Corp (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Jazz Pharmaceuticals (Inst); Kartos Therapeutics (Inst); Pfizer (Inst); Samus Therapeutics (Inst); Sunesis Pharmaceuticals (Inst)
 
Rong Wang
Research Funding - Celgene
 
Steven Gore
Consulting or Advisory Role - ABBVIE/ABBOTT; Amgen (I); SERVIER
Research Funding - Celgene (I)
Travel, Accommodations, Expenses - Abbvie; SERVIER
Other Relationship - Genentech (I)
 
Smith Giri
No Relationships to Disclose
 
Natalia Neparidze
Consulting or Advisory Role - Eidos Therapeutics
Research Funding - Janssen Biotech
 
Scott F. Huntington
Honoraria - AstraZeneca; Pharmacyclics
Consulting or Advisory Role - Abbvie; Bayer; Celgene; Flatiron Health; Genentech; Janssen
Research Funding - Celgene; Debiopharm Group; DTRM; TG Therapeutics
Travel, Accommodations, Expenses - Bayer; Celgene